肝动脉治疗转移性结直肠癌 - Suppr | 超能文献

Hepatic arterial therapy for the treatment of metastatic colorectal cancer.

作者信息

Kemeny N E

机构信息

Department of Gastrointestinal Oncology, Memorial Sloan-Kettering Cancer Center, New York, NY 10021, USA.

出版信息

Semin Oncol. 2000 Oct;27(5 Suppl 10):126-31.

Abstract

摘要

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

文档翻译

学术文献翻译模型，支持多种主流文档格式。

相似文献

1

Hepatic arterial therapy for the treatment of metastatic colorectal cancer.肝动脉治疗转移性结直肠癌

Semin Oncol. 2000 Oct;27(5 Suppl 10):126-31.

2

[The investigational strategy and present status of hepatic arterial infusion chemotherapy for liver metastasis for colorectal cancer].[结直肠癌肝转移肝动脉灌注化疗的研究策略与现状]

Gan To Kagaku Ryoho. 1993 Dec;20(16):2467-71.

3

[Intra-arterial chemotherapy, using the hepatic artery, in metastases of colorectal carcinoma].[经肝动脉进行的动脉内化疗在结直肠癌转移中的应用]

Rev Med Univ Navarra. 1987 Jul-Sep;31(3):169-76.

4

Regional chemotherapy for colorectal cancer metastatic to the liver.针对肝转移结直肠癌的区域化疗。

Oncology (Williston Park). 1988 Mar;2(3):19-26.

5

[Evaluation of hepatic resection following hepatic arterial infusion chemotherapy for colorectal liver metastases].[结直肠癌肝转移肝动脉灌注化疗后肝切除的评估]

Gan To Kagaku Ryoho. 2000 Oct;27(12):1826-9.

6

Hepatic arterial infusion chemotherapy for metastatic colorectal cancer: a concise overview.肝动脉灌注化疗治疗转移性结直肠癌：简要概述

Cancer Treat Rev. 2004 Aug;30(5):425-36. doi: 10.1016/j.ctrv.2004.04.002.

7

[Regional adjuvant therapy in colorectal liver metastases: requirements for clinical therapy studies from the statistical viewpoint].

Zentralbl Chir. 1995;120(10):755-9.

8

[Arterial chemoinfusion for treatment of unresectable malignant tumors of the liver].

Vopr Onkol. 2000;46(5):521-8.

9

Colorectal cancer: hepatic-directed therapy--the role of surgery, regional chemotherapy, and novel modalities.结直肠癌：肝脏靶向治疗——手术、区域化疗及新方法的作用

Semin Oncol. 1995 Oct;22(5):494-508.

10

Updated options for liver-limited metastatic colorectal cancer.肝局限性转移性结直肠癌的最新治疗选择。

Clin Colorectal Cancer. 2008 Dec;7 Suppl 2:S58-62. doi: 10.3816/CCC.2008.s.009.

引用本文的文献

1

Combination of HAI-FUDR and Systemic Gemcitabine and Cisplatin in Unresectable Cholangiocarcinoma: A Dose Finding Single Center Study.不可切除胆管癌中 HAI-FUDR 联合全身吉西他滨和顺铂治疗：一项剂量探索性单中心研究。

Oncology. 2021;99(5):300-309. doi: 10.1159/000512967. Epub 2021 Mar 3.

2

Phase I dose-escalation trial of irinotecan with continuous infusion 5-FU first line, in metastatic colorectal cancer.伊立替康联合持续输注5-氟尿嘧啶一线治疗转移性结直肠癌的I期剂量递增试验。

Br J Cancer. 2004 Oct 18;91(8):1447-52. doi: 10.1038/sj.bjc.6602173.